TNAP Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Homoarginine-d4 Dihydrochloride | 1332075-41-8 | sc-280882 sc-280882-CW sc-280882A | 1 mg 1 mg 10 mg | $331.00 $444.00 $2341.00 | ||
L-Homoarginine-d4 Dihydrochloride is a stable isotopically labeled compound that exhibits unique interactions with nitric oxide synthase, influencing enzymatic activity and metabolic pathways. Its deuterated form enhances the precision of kinetic studies, allowing for detailed analysis of reaction mechanisms. The compound's solubility and stability in various conditions facilitate its use in biochemical assays, providing insights into arginine metabolism and related physiological processes. | ||||||
Levamisole Hydrochloride | 16595-80-5 | sc-205730 sc-205730A | 5 g 10 g | $42.00 $67.00 | 18 | |
Alkaline phosphatase inhibitor indirectly impacting TNAP. Levamisole interferes with the proper folding and maturation of TNAP, leading to reduced enzyme activity. | ||||||
Lansoprazole | 103577-45-3 | sc-203101 sc-203101A | 500 mg 1 g | $58.00 $173.00 | 6 | |
Proton pump inhibitor indirectly affecting TNAP by altering intracellular pH. Lansoprazole inhibits the H+/K+ ATPase in gastric parietal cells, leading to increased acidity in the endoplasmic reticulum and potential misfolding of TNAP. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $45.00 $56.00 $183.00 | 142 | |
Phosphatase inhibitor indirectly influencing TNAP. Sodium orthovanadate inhibits various phosphatases, potentially impacting TNAP activity through modulation of cellular phosphate levels. | ||||||
Sodium pyrophosphate dibasic | 7758-16-9 | sc-251047 sc-251047A sc-251047B | 100 g 200 g 1 kg | $83.00 $114.00 $434.00 | 1 | |
Substrate analog indirectly affecting TNAP. Pyrophosphate competes with TNAP substrates, acting as a competitive inhibitor and potentially reducing enzyme activity. | ||||||
β-Glycerophosphate disodium salt | 819-83-0 | sc-220452 sc-220452A sc-220452B sc-220452C sc-220452D sc-220452E | 25 g 100 g 500 g 1 kg 3 kg 6 kg | $62.00 $117.00 $433.00 $724.00 $2050.00 $3580.00 | 43 | |
TNAP substrate analog influencing TNAP activity. Beta-Glycerophosphate acts as a substrate mimic, potentially enhancing TNAP activity by providing an alternative substrate for the enzyme. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $39.00 $45.00 $98.00 | 26 | |
Phosphatase inhibitor indirectly influencing TNAP. Sodium fluoride inhibits various phosphatases, potentially impacting TNAP activity through modulation of cellular phosphate levels. | ||||||
Ibandronate Sodium Monohydrate | 138926-19-9 | sc-218589 | 100 mg | $290.00 | ||
Bisphosphonate indirectly affecting TNAP. Ibandronate, a bisphosphonate, is involved in bone metabolism and may indirectly impact TNAP activity by influencing the availability of phosphate ions in the extracellular matrix. | ||||||
5′-Deoxy-5′-methylthioadenosine | 2457-80-9 | sc-202427 | 50 mg | $120.00 | 1 | |
Endogenous metabolite influencing TNAP indirectly. 5'-Methylthioadenosine may modulate TNAP activity by affecting cellular signaling pathways or metabolic processes. | ||||||
Vitamin K3 | 58-27-5 | sc-205990B sc-205990 sc-205990A sc-205990C sc-205990D | 5 g 10 g 25 g 100 g 500 g | $25.00 $35.00 $46.00 $133.00 $446.00 | 3 | |
Vitamin K3 impacts TNAP activity. Menadione, a synthetic form of vitamin K, may inhibit TNAP activity. | ||||||